Nivimedone sodium

Immunotag™ Rat NOS1/nNOS (Nitric Oxide Synthase 1, Neuronal) ELISA

A relatively non-selective inhibitor of all NOS isoforms with Ki values 0.18, 0.4, and 6 &microM for nNOs (rat), eNOS (human), and iNOS (mouse), respectively.

L-NMMA is a relatively non-selective inhibitor of all NOS isoforms. It is the archetypal NOS inhibitor to which other inhibitors are most often compared.

L-NMMA is a relatively non-selective inhibitor of all NOS isoforms. It is the archetypal NOS inhibitor to which other inhibitors are most often compared.

L-NMMA is a relatively non-selective inhibitor of all NOS isoforms. It is the archetypal NOS inhibitor to which other inhibitors are most often compared.

L-NMMA is a relatively non-selective inhibitor of all NOS isoforms. It is the archetypal NOS inhibitor to which other inhibitors are most often compared.

L-NNA is an inhibitor of NOS with some selectivity for the neuronal and endothelial isoforms. It exhibits Ki values of 15 nM, 39 nM, and 4.4 &microM for nNOS (bovine), eNOS (human), and iNOS (mouse), respectively.

L-NNA is an inhibitor of NOS with some selectivity for the neuronal and endothelial isoforms. It exhibits Ki values of 15 nM, 39 nM, and 4.4 &microM for nNOS (bovine), eNOS (human), and iNOS (mouse), respectively.

L-NNA is an inhibitor of NOS with some selectivity for the neuronal and endothelial isoforms. It exhibits Ki values of 15 nM, 39 nM, and 4.4 &microM for nNOS (bovine), eNOS (human), and iNOS (mouse), respectively.

L-NNA is an inhibitor of NOS with some selectivity for the neuronal and endothelial isoforms. It exhibits Ki values of 15 nM, 39 nM, and 4.4 &microM for nNOS (bovine), eNOS (human), and iNOS (mouse), respectively.

Lodelaben is a human neutrophil elastase inhibitor with an IC 50 and K i of 0.5 and 1.5 μM, respectively.In VitroLodelaben is a human neutrophil elastase inhibitor with an IC 50 and K i of 0.5 and 1.5 μM, respectively. Results indicate that the

MK 0524 sodium salt is a potent, selective DP1 receptor antagonist with K|i|values of 0.57 nM and 0.75 μM for the DP1 and DP2 receptors, respectively. It inhibits PGD2-induced accumulation of cAMP in both washed platelets and platelet-rich plasma